Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.62 |
| ▸ | CA1 | P00915 | 2/20 | 0.62 |
| ▸ | CA2 | P00918 | 2/20 | 0.62 |
| ▸ | CA7 | P43166 | 2/20 | 0.62 |
| ▸ | CA9 | Q16790 | 2/20 | 0.62 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.55 |
| ▸ | CYP1A1 | P04798 | 6/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 6/20 | 0.54 |
| ▸ | CYP1B1 | Q16678 | 6/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.54 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.48 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | CYP4B1 | P13584 | 1/20 | 0.48 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.48 |
| ▸ | CYP3A5 | P20815 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1045690 | 0.81 | CA12 (0.62) | CA12CA1CA2CA7CA9 | |
| SCHEMBL11786846 | 0.80 | ACHE (0.50) | CA12CA1CA2CA7CA9 | |
| SCHEMBL3033181 | 0.80 | RUNX1 (0.42) | CA12CA1CA2CA7CA9 | |
| SCHEMBL9487248 | 0.78 | CA12 (0.81) | CA12CA1CA2CA7CA9 | |
| 1,2,4-Trimethoxybenzene SCHEMBL29350371 | 0.77 | CA12 (1.00) | CA12CA1CA2CA7CA9 | |
| 1,2,4-Trimethoxybenzene SCHEMBL481491 | 0.77 | CA12 (1.00) | CA12CA1CA2CA7CA9 | |
| 1,2,4-Trimethoxybenzene SCHEMBL27777905 | 0.77 | CA12 (1.00) | CA12CA1CA2CA7CA9 | |
| SCHEMBL1402343 | 0.77 | CA12 (0.52) | CA12CA1CA2CA7CA9 | |
| SCHEMBL1802754 | 0.76 | ACHE (0.62) | CA1CA2CA9ALDH1A1CYP3A4 | |
| SCHEMBL4396937 | 0.76 | CYP1A2 (0.48) | CA12CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 784 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104447646-B | A kind of method complete synthesis for natural product Moracin M | 中科院广州化学有限公司 | 2016-08-31 | — | — | CN | claimed |
| EP-0772616-B1 | HYDROPHILIC METAL COMPLEXES | ROCHE DIAGNOSTICS GMBH (DE) | 1999-12-15 | — | — | EP | claimed |
| US-5541032-A | CHARGE STABILIZERS WHICH ARE INSENSITIVE TO MOISTURE, HEAT RESISTANT AND PRODUCE CRISP, UNIFORM VISIBLE IMAGES OF HIGH COLOR INTENSITY | BASF AKTIENGESELLSCHAFT (DE) | 1996-07-30 | — | — | US | claimed |
| US-12043573-B2 | Adhesion promoters and gel-modifiers for olefin metathesis compositions | MATERIA, INC. (US) | 2024-07-23 | — | — | US | disclosed |
| EP-3386936-B1 | OLEFIN METATHESIS CATALYSTS | UMICORE AG & CO KG (DE) | 2024-07-10 | — | — | EP | disclosed |
| CN-113423549-B | Coating composition | 马特里亚公司 | 2024-06-25 | — | — | CN | disclosed |
| EP-3016991-B1 | LIQUID MOLDING COMPOSITIONS | MATERIA INC (US) | 2024-06-12 | — | — | EP | disclosed |
| WO-2024097151-A1 | ANTIBIOTIC-RESISTANT ARTIFICIAL NUCLEOSIDE, COMPOSITION AND METHOD | CLEVELAND STATE UNIVERSITY (US) | 2024-05-10 | — | — | WO | disclosed |
| US-11958042-B2 | Reactions of olefin derivatives in the presence of metathesis catalysts | UMICORE AG & CO. KG (DE) | 2024-04-16 | — | — | US | disclosed |
| CN-110770230-B | Production of trimethylbenzene derivatives | 罗地亚经营管理公司 | 2024-03-26 | — | — | CN | disclosed |
| US-20240092764-A1 | KINASE INHIBITORS | INSILICO MEDICINE IP LIMITED (HK) | 2024-03-21 | — | — | US | disclosed |
| EP-0422474-A2 | Fluorescent pigments | BASF Aktiengesellschaft (DE) | 1991-04-17 | — | — | EP | disclosed |
| EP-0387613-A1 | Thienodiazepines | BOEHRINGER INGELHEIM KG (DE) | 1990-09-19 | — | — | EP | disclosed |
| US-4898654-A | IRRADIATING INCLUSION COMPLEX | OTSUKA KAGAKU KABUSHIKI KAISHA (JP) | 1990-02-06 | — | — | US | disclosed |
| EP-0351615-A1 | Process for the preparation of 4-alkoxy-2-hydroxybenzophenone-5-sulfonic acids | BASF Aktiengesellschaft (DE) | 1990-01-24 | — | — | EP | disclosed |
| US-4820703-A | TREATMENT OF INFLAMMATORY, RESPIRATORY AND CARDIOVASCULAR DISEASES | YOSHITOMI PHARMACEUTICAL INDUSTRIES LTD. (JP) | 1989-04-11 | — | — | US | disclosed |
| EP-0284099-A2 | Silver halide color photographic materials | FUJI PHOTO FILM CO., LTD. (JP) | 1988-09-28 | — | — | EP | disclosed |
| EP-0268242-A1 | PAF-antagonistic thienotriazolodiazepine compounds and pharmaceutical uses thereof | Yoshitomi Pharmaceutical Industries, Ltd. (JP) | 1988-05-25 | — | — | EP | disclosed |
| EP-0247381-A2 | 5-flurorouracil derivatives | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1987-12-02 | — | — | EP | disclosed |
| US-4309441-A | HYPOTENSIVE AGENTS | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1982-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240092764-A1 | KINASE INHIBITORS | MAP4K4, MAP2K4, MAP4K2 | CA12 4531/4885CA1 3936/4885CA2 2121/4885 |
| US-11958042-B2 | Reactions of olefin derivatives in the presence of metathesis catalysts | SYMPK, MDK, HCK | CA12 3786/4885CA1 3425/4885CA2 4518/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.